food allergy market insight

DelveInsight’s ‘Food Allergy(FA)–Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Food Allergy (FA), historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Food Allergy (FA) market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted FA symptoms market size from 2018 to 2030 segmented by seven major markets. The report also covers current Food Allergy (FA) symptoms treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2018–2030

Food Allergy (FA) Disease Understanding and Treatment Algorithm

Food Allergy (FA) Overview

A Food Allergy (FA) is an adverse health effect arising from a specific immune response that occurs reproducibly on exposure to a given food. Food allergens are the parts of food or ingredients within food (proteins usually) recognized by immune cells. When an immune cell binds to a food allergen, a reaction occurs that causes the symptoms of food allergy (Valenta et al., 2015)

Food intolerances are adverse health effects caused by foods. They do not involve the immune system. For example, if someone is lactose intolerant, they miss the enzyme that breaks down lactose, a sugar found in milk. However, allergy refers to conditions that involve changes to one’s immune system. These immune system changes are divided into two categories: Immunoglobulin E (IgE) mediated and non–IgE-mediated.

Symptoms of a Food Allergy (FA) may range in severity from mild localized oral itching with ingestion of fresh fruits or vegetables in individuals with pollen-food allergy syndrome to life-threatening states in individuals with anaphylactic reactions to foods, such as peanut (Bird et al., 2019).

Food Allergy (FA) symptoms are most common in babies and children, but they can appear at any age. It is a significant public health problem that affects adults and children and may also be increasing in prevalence. Moreover, the diagnosis of a food allergy may be problematic, given that nonallergic food reactions, such as food intolerance, are frequently confused with food allergies (Boyce et al., 2010).

Diagnosis is complicated by the observation that detecting food-specific IgE (sensitization) does not necessarily indicate a clinical allergy. Therefore, diagnosis requires a careful medical history, laboratory studies, and, in many cases, an oral food challenge to confirm a diagnosis. Novel diagnostic methods, including ones that focus on immune responses to specific food proteins or epitopes of specific proteins, are under study (Sicherer & Sampson, 2010).

Food Allergy (FA) Diagnosis and Treatment

It covers the details of conventional and current medical therapies and diagnosis available in the Food Allergy (FA) market to treat the condition. It also provides country-wise treatment guidelines and algorithms across the United States, Europe, and Japan.

The DelveInsight Food Allergy (FA) market report gives a thorough understanding of FA symptoms by including disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides FA symptoms of treatment algorithms and treatment guidelines for FA symptoms in the US, Europe, and Japan.

Food Allergy (FA) Epidemiology

The epidemiology division’s Food Allergy (FA) symptoms provide insights about the historical and current patient pool and the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Food Allergy (FA) epidemiology segmented as the Total Prevalent Cases of Food Allergy (FA), Prevalent cases of FA based on Etiology-specific factors, Age-specific Prevalence of Food allergy. The report includes the prevalent FA scenario in 7MM, covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country Wise- Food Allergy (FA) Epidemiology

The epidemiology segment also provides the Food Allergy (FA) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The total 7MM prevalent cases of Food Allergy (FA) were 56,849,000 in 2020.

Food Allergy (FA) Drug Chapters 

The drug chapter segment of the Food Allergy (FA) report encloses the detailed analysis of FA marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps understand the Food Allergy (FA) clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug, and the latest news and press releases.

Chemotherapy or immunotherapy may be warranted postoperatively, depending on cancer staging and nodal involvement. The surgical nurse practitioner, a member of the medical oncology team, can coordinate the surveillance plan of care and review laboratory results.

Products detail in the report…

Food Allergy (FA) Emerging Drugs

Ligelizumab: Novartis Pharmaceuticals

Ligelizumab (QGE031), a humanized anti-IgE antibody developed by Novartis, is a next-generation monoclonal anti-immunoglobulin E (IgE) antibody. It is also directed against Cε3, but is designed to achieve improved IgE suppression, with an equilibrium dissociation constant (KD) of 139 pM (as compared to the KD of omalizumab, ~6–8 nm) ( Balbino &. Reber, 2018).

Products detail in the report…

Food Allergy (FA) Market Outlook

The Food Allergy (FA) market outlook of the report helps build a detailed comprehension of the historic, current, and forecasted Food Allergy (FA) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand of better technology.

This segment gives a thorough detail of Food Allergy (FA) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on an annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Food Allergy (FA) market in 7MM is expected to change in the study period 2018–2030.

Key Findings

This section includes a glimpse of the Food Allergy (FA) market in 7MM. The market size of FA in the seven major markets was found to be USD 1,091 million in 2020.

The United States Market Outlook

This section provides a total of Food Allergy (FA) market size and market size by therapies in the United States.

The United States accounts for the highest FA market size compared to the EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan.

EU-5 Countries: Market Outlook

The total Food Allergy (FA) market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom are provided in this section.

Japan Market Outlook

The total Food Allergy (FA) market size and market size by therapies in Japan are also mentioned.

Food Allergy (FA) Drugs Uptake

This section focuses on the rate of uptake of the potential drugs recently launched or expected to get launched in the market during the study period 2018–2030. The analysis covers Food Allergy (FA) market uptake by drugs, patient uptake by therapies, and drug sales.

This helps understand the drugs with the most rapid uptake, reasons behind the maximal use of new drugs, and the comparison of the drugs based on market share and size, which will again be useful in investigating factors important in the market uptake in making financial and regulatory decisions.

Food Allergy (FA) Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II and Phase III stage. It also analyses Food Allergy (FA) key players involved in developing targeted therapeutics.

Major players Ligelizumab (Novartis Pharmaceuticals), Viaskin Peanut (DBV Technologies), INP20 (InnoUp Farma S.L.) etc being assessed as potential therapies to be available in the market in the coming future.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition, and merger, licensing, and patent details for Food Allergy (FA) emerging therapies.

KOL Views

To keep up with current market trends, we take KOLs and SME’s opinion working Food Allergy (FA) domain through primary research to fill the data gaps and validate our secondary research. Their opinions help understand and validate current and emerging therapies treatment patterns or Food Allergy (FA) market trends. This will support the clients in potential upcoming novel treatment by identifying the market’s overall scenario and the unmet needs.

Competitive Intelligence Analysis

We perform a Competitive and Market Intelligence analysis of the Food Allergy (FA) Market by using various Competitive Intelligence tools: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies, etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report

• The report covers the descriptive overview of Food Allergy (FA) explaining its causes, signs and symptoms, pathophysiology, and currently available therapies
• Comprehensive insight has been provided into the Food Allergy (FA) epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Food Allergy (FA) is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Food Allergy (FA) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies by understanding trends shaping and driving the global Food Allergy (FA) market

Report Highlights

• In the coming years, Food Allergy (FA) market is set to change due to the rising awareness of the disease and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Food Allergy (FA) R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
• Major players are involved in developing therapies for FA. The launch of emerging therapies will significantly impact the Food Allergy (FA) market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for FA
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Food Allergy (FA) Report Insights

• Patient Population
• Therapeutic Approaches
• Food allergy(FA) Pipeline Analysis
• Food allergy(FA) Market Size and Trends
• Market Opportunities
• Impact of upcoming Therapies

Food Allergy (FA) Report Key Strengths

• 10 Years Forecast
• 7MM Coverage
• Food allergy(FA) Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Market
• Drugs Uptake

Food Allergy (FA) Report Assessment

• Current Treatment Practices
• Unmet Needs
• Pipeline Product Profiles
• Market Attractiveness
• Market Drivers and Barriers

Key Questions

Market Insights:

• What was the Food Allergy (FA) Market share (%) distribution in 2020, and how would it look in 2030?
• What would be the Food Allergy (FA) total market Size as well as market Size by therapies across the 7MM during the forecast period (2021–2030)?
• What are the market’s key findings across 7MM, and which country will have the largest Food Allergy (FA) market Size during the forecast period (2021–2030)?
• At what CAGR, the Food Allergy (FA) market is expected to grow by 7MM during the forecast period (2021–2030)?
• What would be the Food Allergy (FA) market outlook across the 7MM during the forecast period (2021–2030)?
• What would be the Food Allergy (FA) market growth till 2030, and what will be the resultant market Size in the year 2030?
• How would the market drivers, barriers, and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

• What are the disease risk, burden, and unmet needs of Food Allergy (FA)?
• What is the historical Food Allergy (FA) patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Food Allergy (FA) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What will be the growth opportunities in the 7MM concerning the patient population about Food Allergy (FA)?
• Out of all 7MM countries, which country would have the highest prevalent Food Allergy (FA) population during the forecast period (2021–2030)?
• At what CAGR is the population expected to grow by 7MM during the forecast period (2021–2030)?

Current Treatment Scenario, Marketed Drugs, and Emerging Therapies:

• What are the current options for the treatment of Food Allergy (FA)?
• What are the current treatment guidelines for treating Food Allergy (FA) in the USA, Europe, and Japan?
• What are the Food Allergy (FA) marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety, efficacy, etc.?
• How many companies are developing therapies for the treatment of Food Allergy (FA)?
• How many therapies are developed by each company for the treatment of Food Allergy (FA)?
• How many emerging therapies are in the mid-stage and late development stages to treat Food Allergy (FA)?
• What are the key collaborations (Industry–Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Food Allergy (FA) therapies?
• What are the recent novel therapies, targets, mechanisms of action, and technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Food Allergy (FA) and their status?
• What are the key designations that have been granted for the emerging therapies for Food Allergy (FA)?
• What are the global historical and forecasted markets of Food Allergy (FA)?

Reasons to buy

• The report will help in developing business strategies by understanding trends shaping and driving the Food Allergy (FA) market
• To understand the future market competition in the Food Allergy (FA) market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Food Allergy (FA) in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Food Allergy (FA) market
• To understand the future market competition in the Food Allergy (FA) market